ポリ乳酸-グリコール酸（PLGA）の世界市場

ポリ乳酸-グリコール酸（PLGA）の世界市場は2030年までに3億4,920万米ドルに達する見込み

2024年に1億3,690万米ドルと推定されるポリ乳酸-グリコール酸（PLGA）の世界市場は、2030年には3億4,920万米ドルに達し、分析期間2024-2030年のCAGRは16.9%で成長すると予測されます。本レポートで分析したセグメントの一つである高乳酸グレードは、CAGR18.3%を記録し、分析期間終了時には2億5,570万米ドルに達する見込みです。高グリコール酸グレードセグメントの成長率は、分析期間中CAGR13.6％と推定されます。

米国市場は3,730万米ドルと推定、中国はCAGR22.5%で成長すると予測

米国のポリ乳酸-グリコール酸（PLGA）市場は、2024年には3,730万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 22.5％をたどり、2030年までに7,780万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ12.4％と15.3％と予測されています。欧州では、ドイツがCAGR約13.5%で成長すると予測されています。

世界のポリ乳酸-グリコール酸（PLGA）市場- 主要動向と促進要因まとめ

PLGAがバイオメディカルおよび医薬品用途で重要性を増している理由

ポリ乳酸-グリコール酸（PLGA）は、ドラッグデリバリーシステム、医療用インプラント、組織工学、再生医療などに広く使用されている生分解性・生体適合性ポリマーです。無毒性の副生成物（乳酸とグリコール酸）に分解する能力により、薬物放出制御、吸収性縫合糸、整形外科用固定装置、ナノ／微粒子ベースの治療薬に理想的な材料となっています。

ヘルスケアにおける生分解性ポリマーの需要の高まりは、PLGA採用の主要な促進要因です。慢性疾患の世界の増加、ドラッグデリバリーのニーズの高まり、組織再生の進歩が、製薬・バイオメディカル業界におけるPLGAの利用を大きく後押ししています。米国FDA、欧州医薬品庁（EMA）、その他の保健機関による規制承認は、次世代医療におけるPLGAの役割をさらに強固なものにしています。

さらに、PLGAは高度に調整可能であるため、科学者は乳酸（LA）とグリコール酸（GA）の比率を調整することにより、その分解速度、機械的特性、薬物放出動態を変更することができます。この柔軟性により、ナノ粒子、足場工学、バイオセンサー、生体吸収性インプラントなどに広く応用されています。

PLGA技術の革新は、市場の可能性をどのように高めているか？

PLGA市場は、ナノテクノロジー、個別化医療、3Dプリント生物医学材料の進歩に伴って急速に進化しています。

最も重要な技術革新の1つは、ドラッグデリバリーを制御するためのPLGAベースのナノ粒子とマイクロ粒子です。ナノ粒子をベースとした薬物キャリアは、薬物の安定性、溶解性、バイオアベイラビリティを向上させ、持続的かつ局所的な薬物放出を可能にします。PLGAナノ粒子は、腫瘍学、遺伝子治療、ワクチンデリバリー、神経変性疾患治療に広く使用されており、最小限の副作用で標的を絞ったデリバリーを可能にしています。

個別化医療と遺伝子治療の進歩も、次世代ドラッグデリバリーシステムにおけるPLGAの需要を促進しています。科学者たちは、mRNA、CRISPRベースの遺伝子編集、個別化がん治療用のPLGAベースのナノキャリアを設計し、精密医療ソリューションを提供しています。mRNAベースのワクチン（COVID-19ワクチンなど）の成功は、将来のワクチン製剤のためのPLGAベースの脂質ナノ粒子（LNP）代替物の研究を加速させています。

さらに、3DプリントPLGA足場は、組織工学と再生医療に変革をもたらしつつあります。PLGAの生分解性と生体吸収性の特性は、骨、軟骨、軟部組織の再生に理想的です。3DプリントされたPLGA生体材料は現在、個別化インプラント、整形外科用移植片、バイオプリンティング・アプリケーションに使用され、患者のためのカスタマイズされた医療ソリューションを可能にしています。

PLGAと生理活性分子（成長因子、ペプチド、タンパク質など）との統合は、創傷治癒、歯科用途、神経再生におけるPLGAの役割をさらに拡大しつつあります。科学者たちは、PLGAベースのハイドロゲル、ナノファイバー、複合バイオマテリアルを、高度な創傷被覆材や外科手術用途に開発し、患者の回復成果を向上させています。

なぜPLGAの需要はヘルスケアやバイオメディカル分野で伸びているのか？

製薬、医療機器、バイオテクノロジー業界でPLGAの使用が増加していることが、市場拡大の原動力となっています。PLGAの特性の恩恵を受けている主な分野は以下の通りです：

• ドラッグデリバリー：PLGAは、長時間作用型の注射薬、ミクロスフェア・ベースの製剤、標的ナノ粒子治療薬などに広く使用されています。PLGAベースのドラッグデリバリーシステムは、治療効果を向上させ、投与回数を減らし、患者のコンプライアンスを高めるため、腫瘍学、糖尿病、心血管疾患、神経変性疾患に理想的です。
• 医療用インプラントと縫合糸：吸収性縫合糸、整形外科用ピン、スクリュー、固定器具市場は、その生分解性と生体適合性によりPLGAに大きく依存しています。PLGAベースのインプラントは外科的除去の必要性をなくし、患者の不快感や術後の合併症を軽減します。
• 組織工学と再生医療：PLGAスキャフォールドは、骨再生、軟骨修復、軟組織工学に使用されています。PLGAベースの幹細胞デリバリー・プラットフォームの開発により、創傷治癒、人工血管、神経再生への応用がさらに広がっています。
• 生分解性医療機器：PLGAはステントコーティング、バイオセンサー、ナノファイバーベースの創傷被覆材に使用されています。病院や外科医が低侵襲で患者に優しいソリューションを求める中、生分解性医療機器やインプラントの需要が高まっています。
• ワクチン・遺伝子治療開発：PLGAナノ粒子は、mRNAワクチンの安定化、DNAデリバリー、CRISPR遺伝子編集プラットフォームでますます利用されるようになっています。PLGAベースのアジュバントや免疫療法の調査は、世界の感染症対策の高まりとともに加速すると予想されます。

PLGA市場の成長を促す要因は何か？

PLGA市場の成長は、技術の進歩、生分解性医療ソリューションに対する需要の増加、医薬品や再生医療における用途の拡大が原動力となっています。

• ドラッグデリバリー需要の高まり：従来の薬物製剤から長時間作用型の注射剤や標的ナノ粒子治療薬へのシフトにより、ドラッグデリバリー用途におけるPLGAの使用量が大幅に増加しています。
• 生分解性・生体吸収性医療機器の進歩：生体吸収性の縫合糸、ステント、インプラントの採用が増加し、PLGAベースの医療機器の需要を牽引しています。病院や手術センターが患者に優しいソリューションを優先する中、術後治癒や移植可能な薬剤溶出デバイスにおけるPLGAの役割は拡大しつつあります。
• 再生医療への注目の高まり：組織工学と幹細胞治療研究の成長により、PLGAは3Dプリント足場、人工臓器再生、個別化医療用途の主要バイオマテリアルとして位置づけられています。
• 生分解性ポリマーに対する政府・規制当局の支援：FDAやEMAなどの規制機関は、医療用の生分解性・生体吸収性材料を推進しており、PLGAベースのバイオポリマーへの投資拡大につながっています。
• ワクチン・ナノ医療研究への投資拡大：mRNAワクチンプラットフォームと標的ナノ粒子薬物送達の成功により、次世代ワクチン、免疫療法、抗ウイルス治療用のPLGAベースナノキャリアの研究開発が加速しています。
• 持続可能性と生分解性への取り組み：環境に優しい医療ソリューションへの世界のシフトにより、医療廃棄物削減のための生分解性ポリマーへの関心が高まっており、PLGAは石油ベースの医療用プラスチックに代わる持続可能な選択肢として位置づけられています。

ナノ医療、3Dバイオプリンティング、生体工学インプラントなどの技術革新が進む中、PLGA市場は急速に拡大する見通しです。ヘルスケアプロバイダー、製薬会社、バイオテクノロジー企業が生分解性で患者に優しい素材を優先する中、PLGAはドラッグデリバリー、再生医療、先端医療機器開発の将来において重要な役割を担う存在であり続けると思われます。

セグメント

組成（高乳酸グレード、高グリコール酸グレード）、加工性（押出成形、射出成形、その他の加工性）、用途（医療用途、非医療用途）、最終用途（ヘルスケア最終用途、バイオテクノロジー企業最終用途、医療機関最終用途、包装最終用途、繊維最終用途、農業最終用途、その他の最終用途）

調査対象企業の例

• Akina, Inc.
• Ashland Inc.
• Bezwada Biomedical, LLC
• BMG Incorporated
• CD Bioparticles
• Corbion N.V.
• Creative PEGWorks
• Evonik Industries AG
• Green Polymer Corporation
• Jinan Daigang Biomaterial Co., Ltd.
• Kureha Corporation
• LACTEL Absorbable Polymers（Durect Corporation）
• Merck KGaA
• Mitsui Chemicals, Inc.
• Nomisma Healthcare Pvt. Ltd.
• Polysciences, Inc.
• SEQENS
• Shandong Keyuan Pharmaceutical Co., Ltd.
• Sigma-Aldrich Corporation
• Wego Chemical Group

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Poly Lactic-co-Glycolic Acid (PLGA) Market to Reach US$349.2 Million by 2030

The global market for Poly Lactic-co-Glycolic Acid (PLGA) estimated at US$136.9 Million in the year 2024, is expected to reach US$349.2 Million by 2030, growing at a CAGR of 16.9% over the analysis period 2024-2030. High Lactic Acid Grade, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$255.7 Million by the end of the analysis period. Growth in the High Glycolic Acid Grade segment is estimated at 13.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$37.3 Million While China is Forecast to Grow at 22.5% CAGR

The Poly Lactic-co-Glycolic Acid (PLGA) market in the U.S. is estimated at US$37.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$77.8 Million by the year 2030 trailing a CAGR of 22.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.4% and 15.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.5% CAGR.

Global Poly (Lactic-co-Glycolic Acid) (PLGA) Market - Key Trends & Drivers Summarized

Why Is PLGA Gaining Importance in Biomedical and Pharmaceutical Applications?

Poly (Lactic-co-Glycolic Acid) (PLGA) is a biodegradable and biocompatible polymer widely used in drug delivery systems, medical implants, tissue engineering, and regenerative medicine. Its ability to degrade into non-toxic byproducts (lactic acid and glycolic acid) makes it an ideal material for controlled drug release, absorbable sutures, orthopedic fixation devices, and nano/microparticle-based therapeutics.

The rising demand for biodegradable polymers in healthcare is a key driver for PLGA’s adoption. The global burden of chronic diseases, increasing need for targeted drug delivery, and advancements in tissue regeneration have significantly boosted PLGA usage in pharmaceutical and biomedical industries. Regulatory approvals from the U.S. FDA, European Medicines Agency (EMA), and other health agencies have further solidified its role in next-generation medical treatments.

Additionally, PLGA is highly tunable, allowing scientists to modify its degradation rate, mechanical properties, and drug-release kinetics by adjusting the ratio of lactic acid (LA) to glycolic acid (GA). This flexibility has led to widespread applications in nanoparticles, scaffold engineering, biosensors, and bioresorbable implants.

How Are Innovations in PLGA Technology Enhancing Its Market Potential?

The PLGA market is evolving rapidly with advancements in nanotechnology, personalized medicine, and 3D-printed biomedical materials.

One of the most significant innovations is PLGA-based nanoparticles and microparticles for controlled drug delivery. Nanoparticle-based drug carriers improve drug stability, solubility, and bioavailability, allowing for sustained and localized drug release. PLGA nanoparticles are widely used in oncology, gene therapy, vaccine delivery, and neurodegenerative disease treatments, enabling targeted delivery with minimal side effects.

Personalized medicine and gene therapy advancements are also driving demand for PLGA in next-generation drug delivery systems. Scientists are engineering PLGA-based nanocarriers for mRNA, CRISPR-based gene editing, and personalized cancer treatments, offering precision medicine solutions. The success of mRNA-based vaccines (such as COVID-19 vaccines) has accelerated research into PLGA-based lipid nanoparticle (LNP) alternatives for future vaccine formulations.

Additionally, 3D-printed PLGA scaffolds are transforming tissue engineering and regenerative medicine. PLGA’s biodegradable and bioresorbable properties make it ideal for bone, cartilage, and soft tissue regeneration. 3D-printed PLGA biomaterials are now used in personalized implants, orthopedic grafts, and bioprinting applications, enabling customized medical solutions for patients.

The integration of PLGA with bioactive molecules (such as growth factors, peptides, and proteins) is further expanding its role in wound healing, dental applications, and nerve regeneration. Scientists are developing PLGA-based hydrogels, nanofibers, and composite biomaterials for advanced wound dressings and surgical applications, improving patient recovery outcomes.

Why Is Demand for PLGA Growing Across Healthcare and Biomedical Sectors?

The increasing use of PLGA across pharmaceutical, medical device, and biotechnology industries is driving market expansion. Key sectors benefiting from PLGA’s properties include:

• Pharmaceutical Drug Delivery: PLGA is extensively used in long-acting injectable drugs, microsphere-based formulations, and targeted nanoparticle therapeutics. PLGA-based drug delivery systems improve therapeutic efficacy, reduce dosing frequency, and enhance patient compliance, making them ideal for oncology, diabetes, cardiovascular diseases, and neurodegenerative disorders.
• Medical Implants & Sutures: The absorbable sutures, orthopedic pins, screws, and fixation devices market relies heavily on PLGA due to its biodegradability and biocompatibility. PLGA-based implants eliminate the need for surgical removal, reducing patient discomfort and post-operative complications.
• Tissue Engineering & Regenerative Medicine: PLGA scaffolds are being used for bone regeneration, cartilage repair, and soft tissue engineering. The development of PLGA-based stem cell delivery platforms has further expanded its applications in wound healing, vascular grafts, and nerve regeneration.
• Biodegradable Medical Devices: PLGA is being used in stent coatings, biosensors, and nanofiber-based wound dressings. The demand for biodegradable medical devices and implants is growing as hospitals and surgeons seek minimally invasive and patient-friendly solutions.
• Vaccine & Gene Therapy Development: PLGA nanoparticles are increasingly utilized in mRNA vaccine stabilization, DNA delivery, and CRISPR gene-editing platforms. Research into PLGA-based adjuvants and immunotherapies is expected to accelerate with the global rise in infectious disease preparedness.

What Factors Are Driving the Growth of the PLGA Market?

The growth in the PLGA market is driven by technological advancements, increasing demand for biodegradable medical solutions, and expanding applications in pharmaceuticals and regenerative medicine.

• Rising Demand for Controlled Drug Delivery: The shift from conventional drug formulations to long-acting injectables and targeted nanoparticle therapeutics has significantly increased PLGA usage in drug delivery applications.
• Advancements in Biodegradable & Bioresorbable Medical Devices: The rising adoption of bioabsorbable sutures, stents, and implants is driving demand for PLGA-based medical devices. As hospitals and surgical centers prioritize patient-friendly solutions, PLGA’s role in post-operative healing and implantable drug-eluting devices is expanding.
• Increasing Focus on Regenerative Medicine: The growth of tissue engineering and stem cell therapy research has positioned PLGA as a leading biomaterial for 3D-printed scaffolds, artificial organ regeneration, and personalized medicine applications.
• Government & Regulatory Support for Biodegradable Polymers: Regulatory agencies such as the FDA and EMA are promoting biodegradable and bioresorbable materials for medical use, leading to increased investment in PLGA-based biopolymers.
• Growing Investments in Vaccine & Nanomedicine Research: The success of mRNA vaccine platforms and targeted nanoparticle drug delivery has accelerated R&D in PLGA-based nanocarriers for next-generation vaccines, immunotherapies, and antiviral treatments.
• Sustainability & Biodegradability Initiatives: The global shift toward eco-friendly medical solutions is driving interest in biodegradable polymers for medical waste reduction, positioning PLGA as a sustainable alternative to petroleum-based medical plastics.

With ongoing innovations in nanomedicine, 3D bioprinting, and bioengineered implants, the PLGA market is set for rapid expansion. As healthcare providers, pharmaceutical companies, and biotech firms prioritize biodegradable and patient-friendly materials, PLGA will remain a key player in the future of drug delivery, regenerative medicine, and advanced medical device development.

SCOPE OF STUDY:

The report analyzes the Poly Lactic-co-Glycolic Acid (PLGA) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Composition (High Lactic Acid Grade, High Glycolic Acid Grade); Processibility (Extrusion, Injection Molding, Other Processibilities); Application (Medical Application, Non-Medical Application); End-Use (Healthcare End-Use, Biotech Firms End-Use, Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• Akina, Inc.
• Ashland Inc.
• Bezwada Biomedical, LLC
• BMG Incorporated
• CD Bioparticles
• Corbion N.V.
• Creative PEGWorks
• Evonik Industries AG
• Green Polymer Corporation
• Jinan Daigang Biomaterial Co., Ltd.
• Kureha Corporation
• LACTEL Absorbable Polymers (Durect Corporation)
• Merck KGaA
• Mitsui Chemicals, Inc.
• Nomisma Healthcare Pvt. Ltd.
• Polysciences, Inc.
• SEQENS
• Shandong Keyuan Pharmaceutical Co., Ltd.
• Sigma-Aldrich Corporation
• Wego Chemical Group

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Poly Lactic-co-Glycolic Acid (PLGA) - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Biodegradable and Bioresorbable Materials in Drug Delivery Drives Market for PLGA Polymers
  • Strong Adoption of Controlled Release Drug Delivery Systems Supports Use of PLGA in Injectable and Implantable Formulations
  • Regulatory Approvals and Biocompatibility Profile of PLGA Strengthen Its Position in Pharma and Biomedical Applications
  • Growth in Tissue Engineering and Regenerative Medicine Fuels Development of PLGA-Based Scaffolds and Biomaterials
  • Increasing Focus on Sustained Drug Release in Chronic Disease Management Creates Long-Term Demand for PLGA Formulations
  • Advancements in Microencapsulation and Nanoparticle Technology Enhance Precision and Performance of PLGA Systems
  • Widening Application of PLGA in 3D-Printed Medical Devices and Biodegradable Sutures Broadens Its Industrial Relevance
  • Growing Interest in Personalized Medicine Encourages Development of Tailored PLGA-Based Drug Delivery Platforms
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Poly Lactic-co-Glycolic Acid (PLGA) Market Analysis of Annual Sales in US$ for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for High Lactic Acid Grade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for High Lactic Acid Grade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for High Lactic Acid Grade by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for High Glycolic Acid Grade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for High Glycolic Acid Grade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for High Glycolic Acid Grade by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Medical Institutions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Medical Institutions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Medical Institutions End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Packaging End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Packaging End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Packaging End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Textile End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Textile End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Textile End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Agriculture End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Agriculture End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Agriculture End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Healthcare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Healthcare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Healthcare End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Biotech Firms End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Biotech Firms End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Biotech Firms End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Extrusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Extrusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Extrusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Injection Molding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Injection Molding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Injection Molding by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Processibilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Processibilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other Processibilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Medical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Medical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Medical Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Non-Medical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Non-Medical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Non-Medical Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Poly Lactic-co-Glycolic Acid (PLGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• JAPAN
  • Poly Lactic-co-Glycolic Acid (PLGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 82: Japan 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• CHINA
  • Poly Lactic-co-Glycolic Acid (PLGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 83: China Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• EUROPE
  • Poly Lactic-co-Glycolic Acid (PLGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 109: Europe 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• FRANCE
  • Poly Lactic-co-Glycolic Acid (PLGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 110: France Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 121: France 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• GERMANY
  • Poly Lactic-co-Glycolic Acid (PLGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 133: Germany 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 145: Italy 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Poly Lactic-co-Glycolic Acid (PLGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 146: UK Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 157: UK 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 169: Spain 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 181: Russia 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Poly Lactic-co-Glycolic Acid (PLGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Poly Lactic-co-Glycolic Acid (PLGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 220: Australia 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• INDIA
  • Poly Lactic-co-Glycolic Acid (PLGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 221: India Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 232: India 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 244: South Korea 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Poly Lactic-co-Glycolic Acid (PLGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 271: Latin America 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 283: Argentina 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 295: Brazil 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 307: Mexico 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Poly Lactic-co-Glycolic Acid (PLGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 334: Middle East 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 346: Iran 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 358: Israel 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 382: UAE 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030
• AFRICA
  • Poly Lactic-co-Glycolic Acid (PLGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - High Lactic Acid Grade and High Glycolic Acid Grade Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Composition - Percentage Breakdown of Value Sales for High Lactic Acid Grade and High Glycolic Acid Grade for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by End-Use - Percentage Breakdown of Value Sales for Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses, Healthcare End-Use and Biotech Firms End-Use for the Years 2015, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Extrusion, Injection Molding and Other Processibilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Processibility - Percentage Breakdown of Value Sales for Extrusion, Injection Molding and Other Processibilities for the Years 2015, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Medical Application and Non-Medical Application Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 406: Africa 15-Year Perspective for Poly Lactic-co-Glycolic Acid (PLGA) by Application - Percentage Breakdown of Value Sales for Medical Application and Non-Medical Application for the Years 2015, 2025 & 2030

IV. COMPETITION